MedTrace Logo

Allogeneic Umbilical Cord Blood Therapy for Chronic TBI

NCT01451528 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-04-03

No results posted yet for this study

Summary

This open label trial is conducted to investigate the efficacy and safety of umbilical cord blood therapy for chronic traumatic brain injury patients.

The study hypothesis is that the participants will show significant improvement in cognition and function after Umbilical cord blood (UCB) transplantation.

Conditions

Interventions

BIOLOGICAL

Allogeneic Umbilical Cord Blood

Allogeneic Umbilical Cord Blood Transplantation via Intravenous or Intraarterial route

Sponsors & Collaborators

  • Bundang CHA Hospital

    lead OTHER

Principal Investigators

  • Minyoung Kim, M.D., Ph.D. · CHA University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01451528 on ClinicalTrials.gov